Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis

被引：64

作者：

Abrahamyan, Sargis ^{[1
,2
]}

Eberspaecher, Bettina ^{[3
]}

Hoshi, Muna-Miriam ^{[4
]}

Aly, Lilian ^{[4
]}

Luessi, Felix ^{[5
]}

Groppa, Sergiu ^{[5
]}

Klotz, Luisa ^{[6
]}

Meuth, Sven G. ^{[6
]}

Schroeder, Christoph ^{[7
]}

Grueter, Thomas ^{[7
]}

Tackenberg, Bjoern ^{[8
]}

Paul, Friedemann ^{[1
,9
]}

Then-Bergh, Florian ^{[10
]}

Kuempfel, Tania ^{[11
]}

Weber, Frank ^{[12
]}

Stangel, Martin ^{[13
]}

Bayas, Antonios ^{[14
]}

Wildemann, Brigitte ^{[15
]}

Heesen, Christoph ^{[16
]}

Zettl, Uwe ^{[17
]}

Warnke, Clemens ^{[18
,19
,20
]}

Antony, Gisela ^{[21
]}

Hessler, Nicole ^{[22
]}

Wiendl, Heinz ^{[6
]}

Bittner, Stefan ^{[5
]}

Hemmer, Bernhard ^{[4
]}

Gold, Ralf ^{[7
]}

Salmen, Anke ^{[23
]}

Ruprecht, Klemens ^{[1
]}

机构：

[1] Charite Univ Med Berlin, Dept Neurol, Charitepl 1, D-10117 Berlin, Germany

[2] Yerevan State Univ, Yerevan, Armenia

[3] Lab Berlin Charite Vivantes GmbH, Berlin, Germany

[4] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany

[5] Johannes Gutenberg Univ Mainz, Univ Med Mainz, Dept Neurol, Mainz, Germany

[6] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany

[7] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, Bochum, Germany

[8] Philipps Univ Marburg, Dept Neurol, Marburg, Germany

[9] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany

[10] Univ Leipzig, Dept Neurol, Leipzig, Germany

[11] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany

[12] Sana Kliniken Landkreises Cham, Neurol Clin, Cham, Germany

[13] Hannover Med Sch, Dept Neurol, Clin Neuroimmunol & Neurochem, Hannover, Germany

[14] Univ Klinikum Augsburg, Dept Neurol, Augsburg, Germany

[15] Heidelberg Univ, Dept Neurol, Heidelberg, Germany

[16] Univ Hosp Hamburg Eppendorf, Dept Neurol, Hamburg, Germany

[17] Univ Rostock, Dept Neurol, Rostock, Germany

[18] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany

[19] Univ Hosp Cologne, Cologne, Germany

[20] Univ Dusseldorf, Dept Neurol, Dusseldorf, Germany

[21] Philipps Univ Marburg, Cent Informat Off CIO, Marburg, Germany

[22] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Campus Lubeck, Lubeck, Germany

[23] Univ Bern, Univ Hosp Bern, Dept Neurol, Inselspital, Bern, Switzerland

来源：

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2020年 / 91卷 / 07期

关键词：

ENVIRONMENTAL RISK-FACTORS; INFECTION; PREVENTION; EBV;

D O I：

10.1136/jnnp-2020-322941

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective To determine the prevalence of antibodies to Epstein-Barr virus (EBV) in a large cohort of patients with early multiple sclerosis (MS). Methods Serum samples were collected from 901 patients with a clinically isolated syndrome (CIS) or early relapsing-remitting multiple sclerosis (RRMS) participating in the German National MS cohort, a prospective cohort of patients with early MS with stringent inclusion criteria. Epstein-Barr nuclear antigen (EBNA)-1 and viral capsid antigen (VCA) antibodies were measured in diluted sera by chemiluminescence immunoassays (CLIAs). Sera of EBNA-1 and VCA antibody-negative patients were retested undiluted by an EBV IgG immunoblot. For comparison, we retrospectively analysed the EBV seroprevalence across different age cohorts, ranging from 0 to >80 years, in a large hospital population (N=16 163) from Berlin/Northern Germany. Results EBNA-1 antibodies were detected by CLIA in 839 of 901 patients with CIS/RRMS. Of the 62 patients without EBNA-1 antibodies, 45 had antibodies to VCA as detected by CLIA. In all of the remaining 17 patients, antibodies to EBV were detected by immunoblot. Altogether, 901 of 901 (100%) patients with CIS/RRMS were EBV-seropositive. EBV seropositivity increased with age in the hospital population but did not reach 100% in any of the investigated age cohorts. Conclusion The complete EBV seropositivity in this large cohort of patients with early MS strengthens the evidence for a role of EBV in MS. It also suggests that a negative EBV serology in patients with suspected inflammatory central nervous system disease should alert clinicians to consider diagnoses other than MS.

引用

页码：681 / 686

页数：6

共 50 条

[31] Epstein-Barr virus genotypes in multiple sclerosis
Lindsey, J. W.
Patel, S.
Zou, J.
ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (02): : 141 - 144
[32] Epstein-Barr virus and risk of multiple sclerosis
Lily, O
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 192 - 192
[33] Epstein-Barr Virus in pediatric Multiple Sclerosis
Alotaibi, SF
Heurter, H
Ford-Jones, E
Banwell, BL
NEUROLOGY, 2002, 58 (07) : A444 - A445
[34] Epstein-Barr virus as a driver of multiple sclerosis
Sollid, Ludvig M.
SCIENCE IMMUNOLOGY, 2022, 7 (70)
[35] Infection by Epstein-Barr virus and multiple sclerosis
Alonso, A.
Olazabal, N. Egues
Martin, O. Ayo
NEUROLOGIA, 2006, 21 (05): : 249 - 255
[36] Antibodies to Epstein-Barr virus early antigen are increased in multiple sclerosis
Lindsey, J. William
Hatfield, Landon M.
NEUROLOGY, 2008, 70 (11) : A380 - A380
[37] Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis
Lindsey, J. W.
Hatfield, L. M.
Vu, T.
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (10) : 1263 - 1269
[38] Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis
Hon, Gloudina M.
Hassan, Mogamat S.
van Rensburg, Susan J.
Erasmus, Rajiv T.
Matsha, Tandi E.
METABOLIC BRAIN DISEASE, 2012, 27 (03) : 311 - 318
[39] Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis
Sargsyan, S. A.
Shearer, A. J.
Ritchie, A. M.
Burgoon, M. P.
Anderson, S.
Hemmer, B.
Stadelmann, C.
Gattenloehner, S.
Owens, G. P.
Gilden, D.
Bennett, J. L.
NEUROLOGY, 2010, 74 (14) : 1127 - 1135
[40] Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis
Gloudina M. Hon
Mogamat S. Hassan
Susan J. van Rensburg
Rajiv T. Erasmus
Tandi E. Matsha
Metabolic Brain Disease, 2012, 27 : 311 - 318

← 1 2 3 4 5 →